Business
Results of PrimaryBid Offer
Results of PrimaryBid Offer.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n\nTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION.\n \nTHIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES OF OXFORD BIODYNAMICS PLC IN ANY JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. \n \nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (596/2014/EU) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"MAR\"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT SUCH INFORMATION WILL NO LONGER CONSTITUTE INSIDE INFORMATION.\n \nCapitalised terms not otherwise defined herein shall have the meanings given to them in the announcement made by Oxford BioDynamics PLC in respect of the launch of the PrimaryBid Offer on 1 August 2023, unless the context requires otherwise.\n \n4 August 2023\nOxford BioDynamics PLC\nResults of PrimaryBid Offer\nOxford BioDynamics PLC (AIM: OBD, \"OBD\" or \"the Company\"), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, is pleased to announce the successful completion of the PrimaryBid Offer that was announced on 1 August 2023.\nFollowing the successful completion of the Placing and the Subscription, as announced by the Company on 2 August 2023 (the \"Results Announcement\"), retail investors have subscribed via the PrimaryBid platform for a total of 4,941,611 new Ordinary Shares at an issue price of 11p per Ordinary Share, raising gross proceeds of approximately £543,577.\nConsequently, in aggregate, 55,591,035 new Ordinary Shares will be issued pursuant to the Placing, the Subscription and the PrimaryBid Offer, representing approximately 27.5 per cent. of the Company's issued share capital ...